CG
VERA icon

Cutler Group’s Vera Therapeutics VERA Stock Holding History

Cutler Group’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$57K Buy
+1,335
New +$47.6K 0.02% 618

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cutler Group's VERA Position: Q1 2024 in Review

Cutler Group opened a new position in Vera Therapeutics (VERA) in Q1 2024: 1,335 shares worth $57K. The stake represents 0.02% of the portfolio and ranks #618 among its holdings.

160 funds tracked by Wall St. Rank hold VERA as of Q1 2024.

  • Cutler Group held 1,335 shares of Vera Therapeutics worth $57K as of Q1 2024.
  • Vera Therapeutics was a new Cutler Group position in Q1 2024.
  • Vera Therapeutics made up 0.02% of Cutler Group's portfolio in Q1 2024, its #618 holding.
  • 160 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.